The Clinical Efficacy of Immunomodulators in RA Patients

Clinical trial NCT05626348 · RECRUITING

Trial details

NCT number: NCT05626348
Sponsor: Qilu Hospital of Shandong University
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Arthritis, Rheumatoid

Start date: 2021-12-22
Primary completion: 2025-06-30
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.